-
Je něco špatně v tomto záznamu ?
Acinetobacter colistiniresistens sp. nov. (formerly genomic species 13 sensu Bouvet and Jeanjean and genomic species 14 sensu Tjernberg and Ursing), isolated from human infections and characterized by intrinsic resistance to polymyxins
A. Nemec, L. Radolfova-Krizova, M. Maixnerova, O. Sedo,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 1951 do Před 2 roky
Freely Accessible Science Journals
od 2000 do Před 1 rokem
PubMed
28671519
DOI
10.1099/ijsem.0.001903
Knihovny.cz E-zdroje
- MeSH
- Acinetobacter klasifikace genetika izolace a purifikace MeSH
- bakteriální geny MeSH
- bakteriální léková rezistence * MeSH
- DNA bakterií genetika MeSH
- fylogeneze * MeSH
- infekce bakteriemi rodu Acinetobacter mikrobiologie MeSH
- lidé MeSH
- polymyxiny farmakologie MeSH
- RNA ribozomální 16S genetika MeSH
- sekvenční analýza DNA MeSH
- techniky typizace bakterií MeSH
- zastoupení bazí MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Strains of the genusAcinetobacter, classified as genomic species 13BJ/14TU have been previously associated with human infections and resistance to colistin. To clarify the taxonomy of this provisional group, we investigated 24 strains that have been isolated from humans since the 1960s in 10 countries. The genus-wide analysis of the rpoB and gyrB sequences of all strains and whole-genome sequences of strains representing different rpoB/gyrB genotypes showed that the 24 strains formed a distinct monophyletic group within the so-called haemolytic clade of the genus Acinetobacter. The distinctness of the group at the species level was supported by the results of the cluster analysis of the whole-cell protein fingerprints generated by matrix-assisted laser desorption ionization-time-of-flight MS. The 24 strains had very similar metabolic features and could be distinguished from other members of the genus by the combination of strong haemolytic and proteolytic activities and the ability to oxidize d-glucose and grow on phenylacetate and/or l-phenylalanine. The minimum inhibitory concentrations of the 24 strains to colistin and polymyxin B ranged from 16 to 64 mgl-1 and from 4 to 32 mgl-1, respectively, so uniformly reaching the current clinical resistance breakpoint (4 mg l-1) for these drugs. Genus-wide comparison revealed that such a consistently high level of resistance to polymyxins is a unique feature among species of the genus Acinetobacter,which occur in humans. We conclude that genomic species 13BJ/14TU represents a biologically meaningful and medically relevant species, for which the name Acinetobacter colistiniresistens sp. nov. is proposed. The type strain is NIPH 2036T (=CCM 8641T=CIP 110478T=CCUG 67966T=CNCTC 7573T).
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17030707
- 003
- CZ-PrNML
- 005
- 20171025115350.0
- 007
- ta
- 008
- 171025s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1099/ijsem.0.001903 $2 doi
- 035 __
- $a (PubMed)28671519
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Nemec, Alexandr $u 1Laboratory of Bacterial Genetics, National Institute of Public Health, Šrobárova 48, 100 42 Prague, Czech Republic.
- 245 10
- $a Acinetobacter colistiniresistens sp. nov. (formerly genomic species 13 sensu Bouvet and Jeanjean and genomic species 14 sensu Tjernberg and Ursing), isolated from human infections and characterized by intrinsic resistance to polymyxins / $c A. Nemec, L. Radolfova-Krizova, M. Maixnerova, O. Sedo,
- 520 9_
- $a Strains of the genusAcinetobacter, classified as genomic species 13BJ/14TU have been previously associated with human infections and resistance to colistin. To clarify the taxonomy of this provisional group, we investigated 24 strains that have been isolated from humans since the 1960s in 10 countries. The genus-wide analysis of the rpoB and gyrB sequences of all strains and whole-genome sequences of strains representing different rpoB/gyrB genotypes showed that the 24 strains formed a distinct monophyletic group within the so-called haemolytic clade of the genus Acinetobacter. The distinctness of the group at the species level was supported by the results of the cluster analysis of the whole-cell protein fingerprints generated by matrix-assisted laser desorption ionization-time-of-flight MS. The 24 strains had very similar metabolic features and could be distinguished from other members of the genus by the combination of strong haemolytic and proteolytic activities and the ability to oxidize d-glucose and grow on phenylacetate and/or l-phenylalanine. The minimum inhibitory concentrations of the 24 strains to colistin and polymyxin B ranged from 16 to 64 mgl-1 and from 4 to 32 mgl-1, respectively, so uniformly reaching the current clinical resistance breakpoint (4 mg l-1) for these drugs. Genus-wide comparison revealed that such a consistently high level of resistance to polymyxins is a unique feature among species of the genus Acinetobacter,which occur in humans. We conclude that genomic species 13BJ/14TU represents a biologically meaningful and medically relevant species, for which the name Acinetobacter colistiniresistens sp. nov. is proposed. The type strain is NIPH 2036T (=CCM 8641T=CIP 110478T=CCUG 67966T=CNCTC 7573T).
- 650 _2
- $a Acinetobacter $x klasifikace $x genetika $x izolace a purifikace $7 D000150
- 650 _2
- $a infekce bakteriemi rodu Acinetobacter $x mikrobiologie $7 D000151
- 650 _2
- $a techniky typizace bakterií $7 D015373
- 650 _2
- $a zastoupení bazí $7 D001482
- 650 _2
- $a DNA bakterií $x genetika $7 D004269
- 650 12
- $a bakteriální léková rezistence $7 D024881
- 650 _2
- $a bakteriální geny $7 D005798
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a fylogeneze $7 D010802
- 650 _2
- $a polymyxiny $x farmakologie $7 D011113
- 650 _2
- $a RNA ribozomální 16S $x genetika $7 D012336
- 650 _2
- $a sekvenční analýza DNA $7 D017422
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Radolfova-Krizova, Lenka $u 1Laboratory of Bacterial Genetics, National Institute of Public Health, Šrobárova 48, 100 42 Prague, Czech Republic.
- 700 1_
- $a Maixnerova, Martina $u 1Laboratory of Bacterial Genetics, National Institute of Public Health, Šrobárova 48, 100 42 Prague, Czech Republic.
- 700 1_
- $a Sedo, Ondrej $u 2Research Group Proteomics, Central European Institute of Technology and National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.
- 773 0_
- $w MED00006002 $t International journal of systematic and evolutionary microbiology $x 1466-5034 $g Roč. 67, č. 7 (2017), s. 2134-2141
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28671519 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171025115432 $b ABA008
- 999 __
- $a ok $b bmc $g 1254300 $s 991734
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 67 $c 7 $d 2134-2141 $e 20170703 $i 1466-5034 $m International journal of systematic and evolutionary microbiology $n Int. j. syst. evol. microbiol. (Print) $x MED00006002
- LZP __
- $a Pubmed-20171025